Point72 Middle East FZE’s Outset Medical OM Stock Holding History

Point72 Middle East FZE’s Portfolio OM Stock Details OM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,881	Closed	-$153K	–	937
2023 Q4	$153K	Buy	1,881 +1,218	+184%	+$99.1K	﹤0.01%	1105
2023 Q3	$108K	Buy	+663	New	+$156K	﹤0.01%	1131
2023 Q2	–	Sell	-497	Closed	-$137K	–	1922
2023 Q1	$137K	Buy	+497	New	+$182K	﹤0.01%	1037

Other funds holding OM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

MIC

Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return

Point72 Middle East FZE's OM Position: Q1 2024 in Review

Point72 Middle East FZE sold out of Outset Medical (OM) in Q1 2024, closing a stake of 1,881 shares — an estimated $153K sold.

Point72 Middle East FZE first reported a position in OM in Q1 2023 and held it in 3 quarters. The position peaked at $153K in Q4 2023. 114 funds tracked by Wall St. Rank hold OM as of Q1 2024.

Point72 Middle East FZE reported no remaining Outset Medical position as of Q1 2024 after selling out during the quarter.
Point72 Middle East FZE sold 1,881 Outset Medical shares in Q1 2024, an estimated $153K.
Point72 Middle East FZE first reported a position in Outset Medical in Q1 2023 and held it in 3 quarters.
Point72 Middle East FZE's Outset Medical position peaked at $153K in Q4 2023.
114 funds tracked by Wall St. Rank held Outset Medical as of Q1 2024.

Based on Point72 Middle East FZE's 13F filing for Q1 2024.